Spontaneous Haematomas of Psoas Occurring in Intensive Care
NCT ID: NCT03452631
Last Updated: 2022-07-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
40 participants
OBSERVATIONAL
2017-10-01
2017-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Size of Pelvic Hematoma Can be a Predictive Factor for Angioembolization
NCT03519594
Intraoperative Angioembolization in the Management of Pelvic Fracture-Related Hemodynamic Instability
NCT00755365
Benefit of Prophylactic Embolization of the Splenic Salvage
NCT02021396
Auto-administered Questionnaire by Screening of Disorder of the Haemostasis in Preoperative
NCT02886117
Outcome After Conservative and Surgical Treatment of Splenic Injuries After Blunt Abdominal Trauma.
NCT00910182
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Psoas hematoma diagnosed during hospitalization
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Strasbourg, France
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Julie HELMS, MD
Role: STUDY_DIRECTOR
University Hospital, Strasbourg, France
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Service de Réanimation médicale
Strasbourg, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
6838
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.